How has Teleflex's americas — research and development expenses changed year-over-year?

Teleflex's americas — research and development expenses increased by 21.0% year-over-year, from $11.78M to $14.25M.

What does americas — research and development expenses mean?

Represents the investment in innovation, product development, and clinical trials specifically allocated to the Americas segment. These expenditures are critical for maintaining a competitive pipeline of medical technologies and regulatory compliance.

Teleflex TFX Americas — Research and development expenses

Other segment segments

EMEA

$24.5M+257%

Asia

$3.08M-29.4%

Similar metrics at other companies

ZBHAmericas — Research And Development Expense Excluding Acquired In Process Cost

$71.9M+1.1%

MSA

MSAAmericas segment — R&D

$9.64M+2.9%

VRTAmericas — Engineering, research and development costs

$75.6M+50.3%

SSD

SSDNorth America — Research And Development And Other Engineering Expense

$15.91M-9.1%

CARRClimate Solutions Americas — Research and Development Expense

$77M-10.5%

WTSAsia Pacific Middle East And Africa — Research And Development Expense

$700K0.0%

Other financials

Income statement

See full

Revenue$548.3M+32.3%

Gross profit$307.4M+20.4%

Operating income$20.2M-73.4%

Net income-$8.2M-109%

EPS (diluted)-$0.18-109%

Balance sheet

See full

Cash & equivalents$329.6M+16.8%

Total debt$2.8B+38.6%

Total equity$3.1B-24.7%

Total assets$6.8B-5.3%

Cash flow

See full

Operating cash flow$46.7M+68.3%

CapEx$18.8M-22.1%

Free cash flow$27.9M+676%

Valuation

See full

Market cap$5.62B-14.4%

Enterprise value$8.07B-2.0%

P/S2.6×-1.2×

Profitability

See full

Gross margin38.2%-3.0pp

Operating margin3%-11.8pp

Net margin-47.4%-56.2pp

FCF margin7.9%—

Returns & leverage

See full

Return on equity-28.1%-31.6pp

Debt / equity0.9×+0.4×

Current ratio2.6×+0.3×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Teleflex’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teleflex's americas — research and development expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Teleflex's americas — research and development expenses?: Teleflex (TFX) reported americas — research and development expenses of $14.25M in Q1 2026.
How has Teleflex's americas — research and development expenses changed year-over-year?: Teleflex's americas — research and development expenses increased by 21.0% year-over-year, from $11.78M to $14.25M.
What does americas — research and development expenses mean?: Represents the investment in innovation, product development, and clinical trials specifically allocated to the Americas segment. These expenditures are critical for maintaining a competitive pipeline of medical technologies and regulatory compliance.